Skip to main content

Zimmer Biomet Holdings Value Stock - Dividend - Research Selection

Zimmer

ISIN: US98956P1021 , WKN: 753718

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and spinal fusion stimulators. The company\'s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks?

2026-03-16
Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects.

Zimmer Biomet (ZBH) Valuation Check After Earnings Beat And Updated Growth Outlook

2026-03-15
Zimmer Biomet Holdings (ZBH) just reported fourth quarter 2025 results that topped adjusted earnings expectations, alongside 10.9% year over year net sales growth and new guidance for 2026 revenue and earnings. See our latest analysis for Zimmer Biomet Holdings. At a share price of $93.20, Zimmer Biomet’s 1-day share price return of 0.66% and 90-day share price return of 1.76% sit against a 1-year total shareholder return decline of 14.41%, which points to some recent momentum after a weaker...

ISRG's da Vinci Gains FDA Nod for Cardiac Surgery: TAM Growth Ahead?

2026-03-12
ISRG targets cardiac surgery as a long-term da Vinci 5 growth driver after FDA clearance, eyeing nearly 160,000 potential procedures in cleared markets vs approximately 17,000 today.

Why Is Zimmer (ZBH) Down 2% Since Last Earnings Report?

2026-03-12
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Defense Lifts Moat Stocks As Tech Stumbles

2026-03-12
Moat Index gained 2.13% in February, outperforming the S&P 500 by nearly 3 percentage points as defensive rotation favored its equal-weighted, valuation-conscious approach.

3 Healthcare Stocks We Think Twice About

2026-03-11
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 4.1% over the past six months, almost identical to the S&P 500.

ZBH- A Healthcare Equipment Stock for Patient Investors

2026-03-09
“The stock market may not bring you undreamed-of rewards, but if you are willing to get rich slowly, it is the place to make or maintain a fortune,” said Al Frank 31 years ago. Zimmer Biomet Holdings Inc. (ZBH) is a stock to consider, suggests John Buckingham, editor of The Prudent Speculator.

How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Debate Growth And Margins

2026-02-26
Zimmer Biomet Holdings has seen its modeled fair value price target nudged from $102.96 to $102.65, signaling only a very small adjustment in the underlying valuation work. That slight trim comes as analysts remain split, with some highlighting potential upside if execution improves and others pointing to continued questions around growth and margins. As you read on, you will see how these differing views, and any further price target moves, can help you track the evolving story around the...

Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting

2026-02-25
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it will unveil new clinical and operational data and showcase its newest innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting. The company's Chief Movement Officer Arnold Schwarzenegger will take center stage as the conference's Presidential Guest Speaker.

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026

2026-02-23
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2026. The cash dividend of $0.24 per share is payable on or about April 30, 2026 to stockholders of record as of the close of business on March 31, 2026.